FindTrial
Sign In

Study on the Efficacy of Oliceridine in Intravenous Patient-Controlled Analgesia (IV-PCA) for Patients After Cesarean Section

Study on the Efficacy of Oliceridine in Intravenous Patient-Controlled Analgesia (IV-PCA) for Patients After Cesarean Section

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110374
Enrollment
Unknown
Registered
2025-10-13
Start date
2025-10-13
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-cesarean section analgesia

Interventions

Experimental group:Oliceridine
Control group:Sufentanil

Sponsors

Yongzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Singleton pregnant women aged 18-45 years, with a BMI of 20–35 kg/m^2; 2. Gestational age 37-42 weeks, undergoing elective or emergency cesarean section; 3. American Society of Anesthesiologists (ASA) physical status classification II; 4. Voluntarily signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Allergic to opioids or with a history of opioid abuse; 2.Contraindications to oliceridine use, such as severe respiratory depression; 3.Suffering from mental illness or cognitive impairment; 4.Severe insufficiency of major organ function; 5.Preoperative chronic pain; long-term treatment with opioid medications;

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale scroe;Ramsay Sedation Scale scroe;Incidence of Postoperative Nausea and Vomiting;Rescue Analgesic Consumption;—

Countries

China

Contacts

Public ContactChen Lingjun

Yongzhou Central Hospital

clj5087@sina.com+86 746 8819779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026